Sun Pharma is voluntarily recalling 5322 bottles of Ketorolac Tromethamine ophthalmic solution in the US market for failing to meet specifications. Advisory Alert: It has come to our attention ...

Sun Pharma is voluntarily recalling 5,322 bottles of Ketorolac Tromethamine ophthalmic solution in the US market for failing to meet specifications. As per the information available on the USFDA ...

The recent Food and Drug Administration approvals of Zymar (gatifloxacin ophthalmic solution ... nonsteroidal anti-infective drug Acular (ketorolac tromethamine) that can be used in combination ...

The ketorolac tromethamine solution, a generic ... U.S. FDA just recently posted it among its enforcement reports. The ophthalmic drug was produced at Sun's plant in Gujarat, India.

October 22, 2009 — American Regent has issued a voluntary recall of all lots of ketorolac tromethamine injection, 30 mg/mL, the US Food and Drug Administration (FDA) announced yesterday.

Also read: USFDA approves over-the-counter continuous glucose monitoring device Ketorolac tromethamine ophthalmic solution 0.5 per cent is a nonsteroidal, anti-inflammatory medication used to ...

Fresenius Kabi announced the availability of Ketorolac Tromethamine Injection 15mg/mL in Simplist prefilled syringes. Fresenius Kabi announced the availability of Ketorolac Tromethamine Injection ...

Acular LS (ketorolac tromethamine) ophthalmic solution 0.4 percent is indicated for the reduction of ocular pain and burning or stinging following corneal refractive surgery.

Check back regularly for more news from AAO 2019.. SAN FRANCISCO – Administering phenylephrine/ketorolac 1%/0.3% intraocular solution reduces pain and opioid usage during cataract surgery ...